CTMX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

CytomX Therapeutics (CTMX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CTMX is expected to report earnings to fall 392.86% to -20 cents per share on February 26

CytomX Therapeutics CTMX Stock Earnings Reports

Q4'24

Est.

$-0.20

Q3'24

Beat

by $0.24

Q2'24

Beat

by $0.02

Q1'24

Beat

by $0.25

Q4'23

Missed

by $0.03

The last earnings report on November 07 showed earnings per share of 7 cents, beating the estimate of -17 cents. With 1.05M shares outstanding, the current market capitalization sits at 82.95M.

View a ticker or compare two or three

Compare

CTMX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CTMX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

151 Oyster Point Boulevard

Phone

+1 650 515-3185

Employees

122

Web

https://www.cytomx.com